Zobrazeno 1 - 10
of 2 138
pro vyhledávání: '"Cohen IJ"'
Delayed Rewarming Thrombocytopenia: A Suggested Preventable and Treatable Cause of Rewarming Deaths.
Autor:
Cohen IJ; Tel Aviv University Faculty of Medicine, Ramat Aviv.; Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Publikováno v:
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2024 Apr 01; Vol. 46 (3), pp. 138-142. Date of Electronic Publication: 2024 Mar 07.
Autor:
Cohen IJ; Rina Zaizov Department of Pediatric Hematology‑Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Aug 08, pp. e31270. Date of Electronic Publication: 2024 Aug 08.
Autor:
Cohen IJ; Rina Zaizov, Department of Pediatric Hematology‑Oncology, Schneider Children's Medical Center of Israel, Sackler, Petach Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Oct; Vol. 71 (10), pp. e31233. Date of Electronic Publication: 2024 Jul 25.
Autor:
Cohen IJ; Sackler Faculty of Medicine Tel Aviv University, Ramat Aviv, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. Electronic address: icohen@tauex.tau.ac.il.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Apr; Vol. 24 (4), pp. 269-270. Date of Electronic Publication: 2023 Dec 05.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sadeh M; Israel Cancer Association., Toledano H; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.; The Rina Zaizov Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel., Cohen IJ; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.; The Rina Zaizov Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Publikováno v:
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2023 Jan 01; Vol. 45 (1), pp. 1-11. Date of Electronic Publication: 2022 Dec 12.
Autor:
Ghilardi G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Paruzzo L; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA.; Department of Oncology, University of Turin, Turin, Italy., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Shestov AA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Chen L; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Cohen IJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Gabrielli G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA.; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Porazzi P; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Gerson JN; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Carter J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Yelton R; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Pajarillo R; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Patel V; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., White G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Ballard HJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Weber E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Napier E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Chong ER; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Fraietta JA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA., Garfall AL; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Porter DL; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Milone MC; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., O'Connor R; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA., Ruella M; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Publikováno v:
Blood advances [Blood Adv] 2024 Feb 13; Vol. 8 (3), pp. 653-666.
Autor:
Cohen IJ; Tel Aviv University faculty of Medicine, Ramat Aviv and Schneider Children's Medical Center of Israel, Petah Tikva, Israel. Electronic address: icohen@tauex.tau.ac.il.
Publikováno v:
The American journal of emergency medicine [Am J Emerg Med] 2024 Feb; Vol. 76, pp. 274. Date of Electronic Publication: 2023 Nov 18.